Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by CareDx, Inc.

< Previous 1 2 3 Next >
CareDx to Participate in Upcoming Investor Conferences
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Showcases Digital Health Portfolio at 31st Annual UNOS Transplant Management Forum
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Reports First Quarter 2023 Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx to Report First Quarter 2023 Financial Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Showcases Leadership with Over 55 Oral Presentations and Posters at the 43rd Annual Meeting & Scientific Sessions of the International Society for Heart and Lung Transplantation
From CareDx, Inc.
Via Business Wire
Tickers CDNA
National Kidney Foundation Honors CareDx with Corporate Citizenship Award for its Commitment to the Transplant Community
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation
From CareDx, Inc.
Via Business Wire
Tickers CDNA MIRO
CareDx Presents Latest Advancements at 12th Congress of the International Pediatric Transplant Association
From CareDx, Inc.
Via Business Wire
Tickers CDNA
The American Society of Transplant Surgeons Position Statement Supports Use of CareDx’s AlloSure Kidney for Organ Transplant Surveillance
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Update Regarding Raymond James & Associates’ Conference
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx To Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Comments on MolDX Publication of New Billing and Coding Article
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Key Supporter of the National Kidney Foundation’s Annual Kidney Patient Summit
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Reports Fourth Quarter and Full Year 2022 Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Showcases Clinical Value of Multimodality and AI Innovation at the American Society of Transplantation Cutting Edge of Transplantation Meeting
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx to Report Fourth Quarter and Full Year 2022 Financial Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Showcases Latest Advancements in Cellular Transplant and Therapy Including Specialized Digital Health Solutions at the 2023 Tandem Meetings
From CareDx, Inc.
Via Business Wire
Tickers CDNA
JACC Publication Guides Use of CareDx’s HeartCare Transplant Rejection Surveillance in Clinical Practice
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Fosters Transplant Innovation as Distinguished Founder’s Circle Sponsor for the 23rd Annual American Society of Transplant Surgeons State of the Art Winter Symposium
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022
From CareDx, Inc.
Via Business Wire
Tickers CDNA
New ISHLT Guidelines Support Use of CareDx’s HeartCare Solutions, AlloMap and AlloSure, in Routine Monitoring of Heart Transplant Patients
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Announces $50 Million Stock Repurchase Program
From CareDx, Inc.
Via Business Wire
Tickers CDNA
Independent Prospective Study Defines Reference Range for CareDx’s AlloSure for Long-Term Lung Transplant Surveillance
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Committed to Delivering Clinical Innovation to the Transplant Patient and Physician Community
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx To Participate in Upcoming Investor Conferences
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Reports Third Quarter 2022 Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Demonstrates Power of AlloSure and Digital Health Transplant Solutions at American Society of Nephrology Kidney Week
From CareDx, Inc.
Via Business Wire
Tickers CDNA
Independent Longitudinal Study Finds CareDx’s AlloSure Detects Early Signs of Rejection in Pediatric Kidney Transplant Patients
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Congratulates C-Path's Transplant Therapeutics Consortium and Paris Transplant Group for Receiving EMA Draft Qualification for iBox Scoring System
From CareDx, Inc.
Via Business Wire
Tickers CDNA
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.